These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Milosheska D; Lorber B; Vovk T; Kastelic M; Dolžan V; Grabnar I Br J Clin Pharmacol; 2016 Aug; 82(2):399-411. PubMed ID: 27096250 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oral cefatrizine in patients with impaired renal function. Couet W; Fauvel JP; Laville M; Pozet N; Fourtillan JB Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):213-7. PubMed ID: 1869342 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of lamotrigine in patients with epilepsy. Milovanovic JR; Jankovic SM Int J Clin Pharmacol Ther; 2009 Dec; 47(12):752-60. PubMed ID: 19954714 [TBL] [Abstract][Full Text] [Related]
13. [Determination of lamotrigine in the serum and study on pharmacokinetics in rabbits by RP-HPLC]. Hu YS; Wu P; Tang QH Se Pu; 2001 Jul; 19(4):323-5. PubMed ID: 12545490 [TBL] [Abstract][Full Text] [Related]
14. Paracetamol decreases steady-state exposure to lamotrigine by induction of glucuronidation in healthy subjects. Gastrup S; Stage TB; Fruekilde PB; Damkier P Br J Clin Pharmacol; 2016 Apr; 81(4):735-41. PubMed ID: 26588196 [TBL] [Abstract][Full Text] [Related]
15. The effect of raltegravir on the glucuronidation of lamotrigine. van Luin M; Colbers A; Verwey-van Wissen CP; van Ewijk-Beneken-Kolmer EW; van der Kolk M; Hoitsma A; da Silva HG; Burger DM J Clin Pharmacol; 2009 Oct; 49(10):1220-7. PubMed ID: 19717722 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of temocapril and temocaprilat after 14 once daily oral doses of temocapril in hypertensive patients with varying degrees of renal impairment. Püchler K; Eckl KM; Fritsche L; Renneisen K; Neumayer HH; Sierakowski B; Lavrijssen AT; Thomsen T; Roots I Br J Clin Pharmacol; 1997 Dec; 44(6):531-6. PubMed ID: 9431827 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Hussein Z; Posner J Br J Clin Pharmacol; 1997 May; 43(5):457-65. PubMed ID: 9159559 [TBL] [Abstract][Full Text] [Related]
19. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Cohen AF; Land GS; Breimer DD; Yuen WC; Winton C; Peck AW Clin Pharmacol Ther; 1987 Nov; 42(5):535-41. PubMed ID: 3677542 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of lamotrigine. Chan V; Morris RG; Ilett KF; Tett SE Ther Drug Monit; 2001 Dec; 23(6):630-5. PubMed ID: 11802095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]